Univest
Univest
  • Markets

Innova Captab Q1 FY27 Results: Revenue Rs 470 Cr, PAT Rs 44 Cr and Key Highlights

  • August 12, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments

Innova Captab Q1 FY27: Revenue Rs 470 Cr (+33.94% YoY). PAT Rs 44 Cr (+42.27% YoY). Results August 11, 2026. CMP Rs 1,029.

Innova Captab Q1 FY27 results were announced on August 11, 2026, reporting a net profit (PAT) of Rs 44 crore, up 42.27% from Rs 31 crore in Q1 FY26. Revenue from operations grew 33.94% year on year to Rs 470 crore from Rs 351 crore in Q1 FY26. The Innova Captab Q1 FY27 results are on a consolidated basis for the quarter ended June 30, 2026.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Innova Captab Q1 FY27 Financial Highlights
  • Innova Captab Q1 FY27 Performance Analysis
  • Key Business Factors in Innova Captab Q1 FY27
    • 1. Revenue Growth Expanded the Top Line
    • 2. Gross Profit Reflected Operational Gains
    • 3. Net Profit Growth Signals Improving Profitability
  • Dividend Details
  • Innova Captab FY27 Outlook After Q1 Results
  • Innova Captab Stock Performance
  • Key Risks to Watch After Innova Captab Q1 FY27 Results
    • 1. Sector-Specific Demand Headwinds
    • 2. Input Cost and Margin Pressure
    • 3. Macroeconomic and Regulatory Uncertainty
  • Conclusion
  • Frequently Asked Questions on Innova Captab Q1 FY27 Results
    • When were the Innova Captab Q1 FY27 results announced?
    • What is the PAT in the Innova Captab Q1 FY27 results?
    • What was the revenue in the Innova Captab Q1 FY27 results?
    • Did Innova Captab announce any dividend with the Q1 FY27 results?
    • What is the Innova Captab FY27 outlook after Q1 results?
    • Is Innova Captab a good buy after Q1 FY27 results?

Innova Captab Q1 FY27 Financial Highlights

The table below summarises the key financial metrics from the Innova Captab Q1 FY27 results compared with the same quarter of the previous year (Q1 FY26).

Metric Q1 FY27 (Jun 2026) Q1 FY26 (Jun 2025) YoY Change
Revenue from Operations (Rs Cr) Rs 470 Cr Rs 351 Cr +33.94%
Gross Profit (Rs Cr) Rs 61 Cr Rs 41 Cr +49.58%
Net Profit / (Loss) – PAT (Rs Cr) Rs 44 Cr Rs 31 Cr +42.27%

3 Stocks Building Serious Momentum Right Now

When Univest analysts identify high-conviction stock opportunities, investors pay attention.

Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends and growth potential for 2026.

  • Discover stocks investors are actively accumulating
  • High-conviction opportunities backed by research
  • Designed for the next phase of market growth

Unlock the latest Top Stock Picks on Univest

See the Stocks →

Innova Captab Q1 FY27 Performance Analysis

Use the Univest Screener to Track Live Fundamentals of Indian Stocks

Innova captab q1 fy27 results show revenue growth of 33.94% year on year to Rs 470 crore. Gross profit improved to Rs 61 crore from Rs 41 crore in Q1 FY26.

Net profit in the June 2026 quarter stood at Rs 44 crore, a 42.27% increase year on year. Investors tracking Innova Captab quarterly results should verify these figures against the official BSE and NSE filings.

Key Business Factors in Innova Captab Q1 FY27

1. Revenue Growth Expanded the Top Line

Revenue grew 33.94% yoy to rs 470 crore from rs 351 crore a year earlier. Demand conditions in the Pharmaceuticals segment supported the volume and realisation improvement seen in the June 2026 quarter.

2. Gross Profit Reflected Operational Gains

Gross profit improved to Rs 61 crore from Rs 41 crore in Q1 FY26, a 49.58% movement year on year. Better pricing and cost control contributed to the gain.

3. Net Profit Growth Signals Improving Profitability

PAT rose to Rs 44 crore, up 42.27% from Rs 31 crore in Q1 FY26. The profitability improvement reflects the company’s ability to convert revenue growth into bottom-line gains within the Pharmaceuticals space.

Dividend Details

No dividend has been declared alongside the Innova Captab quarterly results for the quarter ended June 2026. Investors may track future announcements via BSE India and NSE India portals.

Innova Captab FY27 Outlook After Q1 Results

Innova Captab Q1 FY27 results set a broadly positive tone for the full financial year. Revenue grew 33.94% yoy to rs 470 crore from rs 351 crore a year earlier and a net profit (PAT) of Rs 44 crore provide a foundation for further improvement. Investors monitoring Innova Captab Q1 results should track demand conditions in Pharmaceuticals, input cost trajectories, and any capacity or business expansion announcements that could shape earnings through the remainder of FY27.

Innova Captab Stock Performance

Download the Univest iOS App or Univest Android App to track Innova Captab live share price and upcoming quarterly results.

Innova Captab share price stood at Rs 1,029 on August 11, 2026, the day the quarterly results were declared. Post-results, the market will assess whether the Pharmaceuticals company’s financial performance justifies the current valuation. Investors should verify the latest price and fundamentals on BSE and NSE before making any investment decision.

Key Risks to Watch After Innova Captab Q1 FY27 Results

1. Sector-Specific Demand Headwinds

A slowdown in the Pharmaceuticals sector could weigh on Innova Captab revenue and profitability beyond what the June 2026 quarter already reflects.

2. Input Cost and Margin Pressure

Rising raw material or operational costs could compress gross margins and limit net profit recovery in subsequent quarters of FY27.

3. Macroeconomic and Regulatory Uncertainty

Inflation, interest rate movements, and regulatory changes remain key risks to the earnings trajectory of Innova Captab through FY27.

Conclusion

Innova Captab Q1 FY27 results report revenue of Rs 470 crore and a net profit (PAT) of Rs 44 crore, up 42.27% from Rs 31 crore in Q1 FY26. The June 2026 quarterly performance reflects the company’s position in the Pharmaceuticals space. Investors should study the full financials on BSE and NSE and consult a SEBI-registered advisor before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Innova Captab Q1 FY27 Results

When were the Innova Captab Q1 FY27 results announced?

Ans. The June 2026 quarterly results for Innova Captab were announced on August 11, 2026, covering the quarter ended June 30, 2026. The consolidated results were filed with BSE and NSE on the same date.

What is the PAT in the Innova Captab Q1 FY27 results?

Ans. PAT (net profit) stood at Rs 44 crore in the June 2026 quarter, up 42.27% from Rs 31 crore in Q1 FY26.

What was the revenue in the Innova Captab Q1 FY27 results?

Ans. Revenue for the June 2026 quarter rose 33.94% year on year to Rs 470 crore from Rs 351 crore in Q1 FY26.

Did Innova Captab announce any dividend with the Q1 FY27 results?

Ans. No dividend has been declared alongside the June 2026 quarterly results. Investors may track future Innova Captab dividend announcements through the BSE and NSE portals.

What is the Innova Captab FY27 outlook after Q1 results?

Ans. The June 2026 quarterly performance signals a positive start to FY27 for Innova Captab. Key factors to watch include revenue trends, margin performance, and Pharmaceuticals sector demand through the rest of the financial year.

Is Innova Captab a good buy after Q1 FY27 results?

Ans. The Q1 FY27 financial performance of Innova Captab reflects improving trends in the June 2026 quarter. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply